Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.66 USD | +1.63% | -0.76% | -0.45% |
06-01 | Delaware judge lets more than 70,000 Zantac lawsuits go forward | RE |
05-31 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
Sales 2024 * | 60.5B 82.47B | Sales 2025 * | 62.72B 85.48B | Capitalization | 162B 221B |
---|---|---|---|---|---|
Net income 2024 * | 6.88B 9.38B | Net income 2025 * | 10.51B 14.33B | EV / Sales 2024 * | 3.66 x |
Net Debt 2024 * | 59.14B 80.6B | Net Debt 2025 * | 54.22B 73.9B | EV / Sales 2025 * | 3.45 x |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
14.7
x | Employees | 88,000 |
Yield 2024 * |
5.83% | Yield 2025 * |
5.94% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | +1.63% | ||
1 week | -0.76% | ||
1 month | +5.45% | ||
3 months | +7.78% | ||
6 months | -0.86% | ||
Current year | -0.45% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 254 M€ | +13.69% | - | |
9.37% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 28.66 | +1.63% | 78,290,055 |
24-05-30 | 28.2 | +1.37% | 23,330,710 |
24-05-29 | 27.82 | -1.70% | 24,241,730 |
24-05-28 | 28.3 | -2.01% | 32,371,217 |
24-05-24 | 28.88 | +0.66% | 22,589,127 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.45% | 162B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PFE Stock